# Alpha Enhanced Europe -UCITS ETF CAPITALISATION- Capitalisation (AEGB) **Page:** https://fundology.uk/fund/aegb · ISIN LU2993402101 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, AEGB (Alpha Enhanced Europe -UCITS ETF CAPITALISATION- Capitalisation, ISIN LU2993402101) closed at £10.79 on the London Stock Exchange. Its ongoing charge is 0.45% a year (about £45 on £10,000). Over the year to 13/11/2026 its total return was +13.6%, or +9.5% after UK CPIH inflation. ## Summary BNP Paribas Easy SICAV -Alpha Enhanced Europe -UCITS ETF CAPITALISATION- Capitalisation is an exchange-traded fund (ETF) from BNP Paribas, launched in 2025. It tracks the No Underlying Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.45% a year — about £45 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£10.79** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | AEGB | | ISIN | LU2993402101 | | Also listed as | AEUR (London Stock Exchange, euros), EDEJ (Xetra, euros) | | Category | European shares | | Type | ETF | | Provider | BNP Paribas | | Income | Accumulating | | Ongoing charge | 0.45% a year (£45 per £10,000) | | Fund size | £53.3m | | Launched | 2025 | | Domicile | Luxembourg | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +13.56% | +9.54% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Charges compared with similar funds Ongoing charge of BNP Paribas Easy SICAV -Alpha Enhanced Europe -UCITS ETF CAPITALISATION- Capitalisation 0.45% a year. Compared on 14/11/2026, 22 of the 242 other European share funds charge more, 3 the same and 217 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.45%** per year (as of 13/10/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds As of 11/11/2026, AEGB holds 213 positions, according to its published holdings. The largest is ASML at 4.31% of the fund; the ten largest make up 22.1%. ### Top holdings Largest positions (as of 11/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | ASML | [ASML](https://fundology.uk/stock/ASML) | 4.31% | | 2 | Novartis | [NOVN](https://fundology.uk/stock/NOVN) | 2.61% | | 3 | Roche | [RO](https://fundology.uk/stock/RO) | 2.58% | | 4 | Shell | [SHEL](https://fundology.uk/stock/SHEL) | 2.45% | | 5 | HSBC | [HSBA](https://fundology.uk/stock/HSBA) | 1.93% | | 6 | Allianz | [ALV](https://fundology.uk/stock/ALV) | 1.87% | | 7 | AstraZeneca | [AZN](https://fundology.uk/stock/AZN) | 1.75% | | 8 | Iberdrola | [IBE](https://fundology.uk/stock/IBE) | 1.53% | | 9 | Nestle | [NESN](https://fundology.uk/stock/NESN) | 1.52% | | 10 | TotalEnergies | [TTE](https://fundology.uk/stock/TTE) | 1.52% | ## Where it invests Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed. ### By country Added up from the fund’s published holdings, as of 04/11/2026. | Country | Weight | |---|---| | United Kingdom | 21.3% | | Switzerland | 16.0% | | Germany | 13.3% | | France | 10.9% | | Netherlands | 9.6% | | Spain | 8.5% | | Italy | 4.4% | | Sweden | 2.7% | | Other countries | 12.2% | All 213 holdings: https://fundology.uk/fund/aegb/holdings ## Questions people ask **What is the ongoing charge of AEGB?** The ongoing charge of AEGB is 0.45% a year — about £45 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of BNP Paribas Easy SICAV -Alpha Enhanced Europe -UCITS ETF CAPITALISATION- Capitalisation 0.45% a year. Compared on 14/11/2026, 22 of the 242 other European share funds charge more, 3 the same and 217 less (share classes counted once). **Is AEGB accumulating or distributing?** AEGB is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of AEGB?** The ISIN of AEGB is LU2993402101. An ISIN identifies one exact share class of a fund; AEGB is its ticker on the London Stock Exchange. The same share class is also listed as AEUR (London Stock Exchange, euros) and EDEJ (Xetra, euros). **What does AEGB hold?** As of 11/11/2026, AEGB holds 213 positions, according to its published holdings. The largest is ASML at 4.31% of the fund; the ten largest make up 22.1%. Its ten largest holdings are ASML (4.31%), Novartis (2.61%), Roche (2.58%), Shell (2.45%), HSBC (1.93%), Allianz (1.87%), AstraZeneca (1.75%), Iberdrola (1.53%), Nestle (1.52%) and TotalEnergies (1.52%). **How has AEGB done after inflation?** Over the year to 13/11/2026 AEGB’s total return was +13.6%, or +9.5% after UK CPIH inflation. Past performance is not a guide to future returns. ## Fund documents - [Fund page at BNP Paribas Asset Management](https://www.bnpparibas-am.com/en-gb/fundsheet/equity/bnp-paribas-easy-alpha-enhanced-europe-ucits-etf-c-lu2993402101) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.